Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Specialized medicine - private practice. Per the activity note to the FY2024 annual report, the company carries out specialized medical practice and manufactures orthopedic devices.
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | N/A | 58.9% | 55.2% | 52.6% | 55.4% | 61.0% | 66.0% | 64.1% |
| EBITDA Margin | N/A | -0.8% | 7.8% | -23.2% | -4.5% | 15.9% | 9.2% | 9.3% |
| EBITDAR | -195 | -6 | 76 | -169 | -44 | 168 | 78 | 82 |
| EBITDAR Margin | N/A | -0.8% | 7.8% | -23.2% | -4.5% | 15.9% | 9.2% | 9.3% |
| EBIT Margin | N/A | -6.5% | 3.3% | -29.2% | -9.1% | 11.9% | 4.6% | 4.9% |
| Net Profit Margin | N/A | -0.8% | -1.3% | -23.2% | -4.5% | 8.5% | 1.2% | 5.5% |
| Operating Expense % of Sales | N/A | 59.6% | 47.4% | 75.7% | 60.0% | 45.0% | 56.9% | 54.7% |
| Returns | ||||||||
| Return on Assets (ROA) | 11.9% | -0.4% | -0.8% | -10.6% | -3.0% | 6.7% | 0.8% | 3.5% |
| Return on Equity (ROE) | 20.7% | -0.6% | -1.4% | -21.5% | -5.9% | 10.9% | 1.2% | 5.4% |
| ROIC [EBIT / Invested Capital] | -12.5% | -3.3% | 2.1% | -14.3% | -6.8% | 9.6% | 3.0% | 3.3% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 41.8% | 41.1% | 38.7% | 47.7% | 42.4% | 37.0% | 35.5% | 33.9% |
| Debt-to-Equity | 0.73x | 0.71x | 0.67x | 0.97x | 0.83x | 0.60x | 0.56x | 0.53x |
| Debt-to-EBITDA | N/A | N/A | 8.12x | N/A | N/A | 2.95x | 6.08x | 5.74x |
| Equity-to-Assets | 57.3% | 58.1% | 57.7% | 49.2% | 50.9% | 61.9% | 63.2% | 64.5% |
| Net Debt | 620 | 630 | 588 | 709 | 549 | 482 | 462 | 400 |
| Cash & Equivalents | 65 | 31 | 29 | 51 | 70 | 14 | 11 | 68 |
| Total Debt | 685 | 661 | 617 | 761 | 618 | 497 | 473 | 468 |
| Liquidity & working capital | ||||||||
| Current Ratio | 1.41x | 16.00x | 0.72x | 1.18x | 2.86x | 1.35x | 2.24x | 7.16x |
| Quick Ratio | 1.41x | 16.00x | -3.05x | -2.83x | 2.86x | 1.35x | 2.24x | 7.16x |
| Cash Ratio | 0.92x | 15.50x | 0.51x | 1.03x | 0.71x | 1.18x | 0.89x | 3.08x |
| Total Current Assets | 100 | 32 | 41 | 59 | 279 | 17 | 27 | 157 |
| Total Current Liabilities | 71 | 2 | 57 | 50 | 98 | 12 | 12 | 22 |
| Inventory | N/A | N/A | 215 | 201 | N/A | N/A | N/A | N/A |
| Trade Receivables | N/A | 59 | 45 | 64 | 37 | 16 | 27 | 90 |
| Trade Payables | 3 | 2 | 57 | 50 | 98 | 11 | 12 | 22 |
| Net Working Capital | 29 | 30 | -16 | 9 | 182 | 4 | 15 | 135 |
| Net Working Capital % of Revenue | N/A | 3.8% | -1.6% | 1.2% | 18.8% | 0.4% | 1.8% | 15.5% |
| Trade Working Capital | -3 | 57 | 203 | 214 | -61 | 5 | 15 | 68 |
| Trade Working Capital % of Revenue | N/A | 7.2% | 20.8% | 29.4% | -6.3% | 0.5% | 1.8% | 7.7% |
| Change in Trade Working Capital | N/A | 60 | 146 | 11 | -275 | 66 | 10 | 53 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | N/A | N/A | 2.03x | 1.72x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | 180.0 | 211.9 | N/A | N/A | N/A | N/A |
| Receivables Turnover | N/A | 13.36x | 21.64x | 11.46x | 26.28x | 67.29x | 31.41x | 9.75x |
| Days Sales Outstanding (DSO) | N/A | 27.3 | 16.9 | 31.8 | 13.9 | 5.4 | 11.6 | 37.4 |
| Payables Turnover | 65.00x | 162.00x | 7.65x | 6.90x | 4.41x | 39.04x | 23.89x | 14.28x |
| Days Payable Outstanding (DPO) | 5.6 | 2.3 | 47.7 | 52.9 | 82.8 | 9.3 | 15.3 | 25.6 |
| Cash Conversion Cycle | -5.6 days | 25.1 days | 149.1 days | 190.8 days | -68.9 days | -3.9 days | -3.7 days | 11.9 days |
| Asset Turnover | 0.00x | 0.49x | 0.61x | 0.46x | 0.66x | 0.79x | 0.64x | 0.63x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | N/A | 60 | 154 | 328 | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | 59 | 152 | 328 | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 202.6% | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →